Black Rose Industries Limited · BSE:BLACKROSE
Black Rose Industries — FY2022 Earnings Presentation
18 slides from Black Rose Industries's earnings presentation, May 5, 2022
Slide 1: FY2021-22 Earnings Webinar
BLACK ROSE INDUSTRIES LTD. FY2021-22 EARNINGS WEBINAR May 5, 2022 Mr. Anup Jatia – Executive Director Mr. Ambarish Daga – Joint CFO and Investor Relations Officer August 24, 2021
Slide 2: Disclaimer
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by BLACK ROSE INDUSTRIES LTD. (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendati
Slide 3: Business presence of Black Rose
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Polyacrylamide Business presence solid - 10,000 MTPA of Black Rose Acrylamide liquid – (in R&D) N-methylol 32,000 MTPA acrylamide (NMA) - 2,000 Chemical (20,000 MTPA for merchant MTPA distribution sales and 12,000 MTPA for Chemical captive require
Slide 4: Financials – Profit & Loss (Standalone & Consolidated)
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Financials – Profit & Loss (Standalone & Consolidated) INR. in millions STANDALONE CONSOLIDATED Particulars YE FY22 YE FY21 Change % YE FY22 YE FY21 Change % Revenue from operations 3,418.82 2,350.99 45% 4,878.84 3,797.82 28% EBITDA 444.28 396.04
Slide 5: Financials – Balance Sheet (Standalone & Consolidated)
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Financials – Balance Sheet (Standalone & Consolidated) INR in millions All ratios on basis of Standalone figures STANDALONE CONSOLIDATED Return on Equity (%) Particulars YE FY22 YE FY21 YE FY22 YE FY21 30.00% Sources of Funds Equity Share Capital
Slide 6: Financials – (Standalone)
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Financials – (Standalone) Total revenue and EBITDA INR in millions Highlights 4,000 500 3,500 444 450 • Highest annual revenue and EBITDA R 3,000 396 400 E in the company’s history with a E 350 V 2,500 B 300 I increase of 45% in the topline over E
Slide 7: Financials – Revenue and geographic mix
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Financials – Revenue and geographic mix 1% 1% MANUFACTURING 32 31 % % DISTRIBUTION 67 68 % % OTHERS YE FY21 YE FY22 10 8% % EXPORTS LOCAL 92 90 % % Figures rounded off to closest unit percentage 7
Slide 8: Financials - Distribution
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Financials - Distribution Total distribution revenue and EBITDA index 2500 INR in millions Highlights 2000 • The overall revenue from the distribution 1500 segment was up by 48% from the previous 2340 year. 1000 1584 • Products like acrylonitrile,
Slide 9: Financials - Manufacturing
INVESTOR Q3 PRESENTATION FY2021-22 2020 EARNINGS WEBINAR Financials - Manufacturing Total manufacturing revenue and EBITDA index INR in millions Highlights 1200 • Overall revenues increased by 41% 1000 while that of PAM-L increased by 800 over 300% compared to the 600 previous year 1067 400 755 • Th
Slide 10: Acrylonitrile – Acrylamide Price Trend
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Acrylonitrile – Acrylamide Price Trend 2,975 3,000 115 2,800 2,700 95 2,600 2,453 2,645 2,338 2,318 2,300 2,400 2,253 2,463 2,233 2,230 75 2,150 2,200 2,334 ACN Price USD/MT 2,200 2,203 2,206 2,173 1,970 2,000 2,155 2,167 55 1,835 1,800 1,948 1,85
Slide 11: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Chemical distribution Business expected to remain strong. Supply chain is a critical aspect for all companies and availability of reliable supplies becomes more important
Slide 12: Outlook for the current quarter: Acrylamide liquid
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Acrylamide liquid Domestic market to be subdued during Q1 FY23. Expect recovery by end May/early June with end of COVID lockdown in China. Demand to grow in FY23 with in
Slide 13: Outlook for the current quarter: PAM Liquid and NMA
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing PAM Liquid N-methylol acrylamide (NMA) Looking to increase market share starting June Expecting product approvals from key clients 2022 as ceramic tile production normal
Slide 14: Outlook for the current quarter: Acrylamide Powder, Polycarboxylate Acid
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Acrylamide Powder Polycarboxylate Acid Expecting approvals very shortly Currently in R&D phase, expecting finalization by end of Q1 FY23 Orders already in hand from Fr
Slide 15: Outlook for the current quarter: Polyacrylamide Solid
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Polyacrylamide Solid Head of Technology hired in March’22 Induction of R&D/technical advisor from Japan at the end of May will boost development effort and fast track pr
Slide 16: Focus on R&D
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Focus on R&D Setting up new world class R&D centre in the outskirts of Mumbai for product and application development Focus on green chemistries for production of tradit
Slide 17: Manufacturing business Capacities and CAPEX
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Manufacturing business Capacities and CAPEX Product Capacity CAPEX in Rs. Incurred in Technology Further Available MTPA Crores* Rs. Crores* possibility capacity for MTPA growth Acrylamide (L) 20,000 + MCI 60,000 30% 12,000 Polyacrylamide (L) 40,00
Slide 18: Contact
INVESTOREARNINGS FY2021-22 PRESENTATION 2020 WEBINAR Contact Mr. Ambarish Daga Joint CFO & Investor Relations Officer Head office 145/A, Mittal Towers Nariman Point, Mumbai 400 021, India Call / Fax +91-22-4333-7200 +91-22-2287-3022 (Fax) Mail to [email protected]